Maternal serum calcitriol during pregnancy and risk of childhood onset type 1 diabetes

  • Ingvild M. Sørensen
  • Geir Joner
  • Pål A. Jenum
  • Anne Eskild
  • Sandra R. Dahl
  • Lars C. Stene
Short Communication

Supplementary material

592_2017_1045_MOESM1_ESM.pdf (441 kb)
Supplementary material 1 (PDF 441 kb)

References

  1. 1.
    Tamblyn JA, Hewison M, Wagner CL, Bulmer JN, Kilby MD (2015) Immunological role of vitamin D at the maternal-fetal interface. J Endocrinol 224:R107–R121CrossRefPubMedGoogle Scholar
  2. 2.
    Brannon PM, Picciano MF (2011) Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr 31:89–115CrossRefPubMedGoogle Scholar
  3. 3.
    Sørensen IM, Joner G, Jenum PA et al (2016) Vitamin D-binding protein and 25-hydroxyvitamin D during pregnancy in mothers whose children later developed type 1 diabetes. Diabetes Metab Res Rev 32:883–890CrossRefPubMedGoogle Scholar
  4. 4.
    Srikanth P, Chun RF, Hewison M et al (2016) Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men. Osteoporos Int 27:2291–2300CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l. 2017

Authors and Affiliations

  • Ingvild M. Sørensen
    • 1
  • Geir Joner
    • 1
    • 2
  • Pål A. Jenum
    • 2
    • 3
  • Anne Eskild
    • 2
    • 4
  • Sandra R. Dahl
    • 5
  • Lars C. Stene
    • 6
  1. 1.Division of Paediatric and Adolescent MedicineOslo University HospitalNydalen, OsloNorway
  2. 2.Institute of Clinical MedicineUniversity of OsloOsloNorway
  3. 3.Department of Laboratory Medicine, Medical MicrobiologyVestre Viken Hospital TrustOsloNorway
  4. 4.Department of Obstetrics and GynaecologyAkershus University HospitalOsloNorway
  5. 5.Hormone Laboratory, Department of Medical BiochemistryOslo University HospitalOsloNorway
  6. 6.Division of EpidemiologyNorwegian Institute of Public HealthOsloNorway

Personalised recommendations